epigenetics

A new research report from Grand View Research inc, charts that the international epigenetics market is due to reach US$16.31 billion by 2022. The forecasted growth being fuelled by the increasing f...

For Dr Hella Kohlhof, the study of epigenetics was not love at first sight, however the potential it posesses eventually won her over. Now Dr Kohlhof is Manager of Translational Pharmacology at 4SC...

Clinically-approved epigenetic therapies are currently effective in only one area: leukaemia. But this belies their true potential. Treatments in development are rapidly expanding across disciplinar...

Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigen...

Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigen...

Epigenetics has been at the forefront of genetic research for over 15 years and the full potential of these druggable targets is finally being realised. Although most research has focused on cancer...

Malaria is one of the world's largest public health problems and treatments for the disease still leave a lot to be desired. Dr Matthew Fuchter and his team have taken a novel approach to malari...

The old argument of nature vs nurture has been known to be a false dilemma for a long time, the true making of an organism lies in both and no topic illustrates this better than epigenetics. Epigene...

In its latest analysis, IMS Health predicted oncology would remain the leading therapeutic class until 2015, although growth was expected to slow as existing targeted therapies are now widely adopte...

Malaria is one of the world's largest public health problems and treatments for the disease still leave a lot to be desired. Dr Matthew Fuchter and his team from Imperial College London, have ta...